Correlation between Anthrax Lethal Toxin Neutralizing Antibody Levels and Survival in Guinea Pigs and Nonhuman Primates Vaccinated with the AV7909 Anthrax Vaccine Candidate

The anthrax vaccine candidate AV7909 is being developed as a next generation vaccine for a post-exposure prophylaxis (PEP) indication against anthrax. AV7909 consists of the Anthrax Vaccine Adsorbed (AVA, BioThrax(®)) bulk drug substance adjuvanted with the immunostimulatory oligodeoxynucleotide (OD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccine
Main Authors: Savransky, Vladimir, Shearer, Jeffry D., Gainey, Melicia R., Sanford, Daniel C., Sivko, Gloria S., Stark, Gregory V., Li, Na, Ionin, Boris, Lacy, Michael J., Skiadopoulos, Mario H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5580334/
https://ncbi.nlm.nih.gov/pubmed/28774566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2017.07.076
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados